Samrat Pharmachem informs about credit rating

03 Jun 2025 Evaluate
Samrat Pharmachem has informed that Crisil Limited has upgraded its rating on the bank facilities to ‘Crisil BBB- /Stable/Crisil A3’ from 'Crisil BB+/Stable/Crisil A4+. Details enclosed.

The above information is a part of company’s filings submitted to BSE.

Samrat Pharmachem Share Price

253.30 1.00 (0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×